A Trial of Degarelix in Patients With Prostate Cancer

NCT00946920 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

859

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Degarelix
DRUG: Goserelin acetate

Sponsor

Ferring Pharmaceuticals